Brasofensine
Brasofensine
Brasofensine (pronunciation: bra-so-fen-sine) is a pharmacological compound that was initially developed for the treatment of Parkinson's disease and depression. It functions as a dopamine reuptake inhibitor, which means it increases the levels of dopamine in the brain by slowing the rate at which it is reabsorbed into the nerve cells.
Etymology
The term "Brasofensine" is a coined pharmaceutical name. The exact etymology is not known, but it is common for pharmaceutical drugs to have names that are derived from their chemical structure or function.
Pharmacology
Brasofensine is a dopamine reuptake inhibitor, which means it works by blocking the reuptake of dopamine, a neurotransmitter, into the presynaptic neuron. This increases the amount of dopamine available in the synaptic cleft, which can then bind to and activate dopamine receptors on the postsynaptic neuron. This mechanism of action is thought to be beneficial in conditions like Parkinson's disease and depression, where dopamine levels are often low.
Related Terms
- Dopamine: A neurotransmitter that plays several important roles in the brain and body.
- Dopamine reuptake inhibitor: A type of drug that increases the levels of dopamine in the brain by slowing the rate at which it is reabsorbed into the nerve cells.
- Parkinson's disease: A long-term degenerative disorder of the nervous system that mainly affects the motor system.
- Depression: A mental health disorder characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life.
External links
- Medical encyclopedia article on Brasofensine
- Wikipedia's article - Brasofensine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski